Cohort 2: 2.5x10^8 PolyTregs ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
35Pemphigus1

35. Pemphigus


Clinical trials : 98 Drugs : 126 - (DrugBank : 41) / Drug target genes : 23 - Drug target pathways : 168
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03239470
(ClinicalTrials.gov)
October 10, 20172/8/2017Polyclonal Regulatory T Cells (PolyTregs) for PemphigusA Phase I, Open-Label, Multicenter Trial Exploring the Safety and Tolerability of Autologous Polyclonal Regulatory T Cell Therapy in Adults With Active Pemphigus (APG01)Pemphigus Foliaceus;Pemphigus VulgarisBiological: Cohort 1: 1.0 x 10^8 PolyTregs;Biological: Cohort 2: 2.5x10^8 PolyTregsNational Institute of Allergy and Infectious Diseases (NIAID)Autoimmunity Centers of Excellence;Rho Federal Systems Division, Inc.Active, not recruiting18 Years75 YearsAll4Phase 1United States